Skip to main content
. 1999 Sep;37(9):2936–2942. doi: 10.1128/jcm.37.9.2936-2942.1999

TABLE 1.

CDV isolates and CDV-positive clinical specimens

Strain source and strain Date and place of collection (Japan) Vaccination historya Age and clinical signs of patient Type by RFLP analysis with:
NdeI FbaI
Field isolates
 KDK-1 1991, Ibaraki Puppy; canine distemper? (no specification) KDK-1 KDK-1
 C710D 1994, Mie Unknown 2 mo; respiratory and nervous signs, bloody diarrhea KDK-1 KDK-1
 C714D 1994, Hokkaido 6 mo; lameness of right hind leg, nasal discharge KDK-1 KDK-1
 C717D 1994, Hokkaido + 10 mo; diarrhea, convulsion KDK-1 KDK-1
 C720D 1994, Hokkaido + 7 mo; nervous signs KDK-1 KDK-1
Rectal swab
 97-050b 1997, Okayama 2 mo; diarrhea, coughing, eye discharge, hard pad NPc NP
 97-063b 1997, Tochigi Unknown 4 mo; canine distemper? (no specification) NP NP
 98-001d 1998, Hokkaido Unknown Puppy; diarrhea KDK-1 KDK-1
 98-002e 1998, Chiba 2 mo; diarrhea, hypersalivation, nervous signs 98-002 KDK-1
Oral swab
 98/001e 1998, Chiba 2 mo; diarrhea, hypersalivation, nervous signs 98-002 KDK-1
 98/003 1998, Chiba 2 mo; nasal discharge, vomiting, tonsillitis KDK-1 KDK-1
 98/005 1998, Chiba 2 mo; vomiting, respiratory signs KDK-1 KDK-1
a

Combined modified live CDV vaccine. 

b

Samples 97-050 and 97-063 were positive for coronavirus. 

c

NP, not performed. 

d

Sample 98-001 was positive for canine parvovirus and reovirus. 

e

Taken from the same patient.